DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)
17.45
+0.39 (2.29%)
Apr 15, 2026, 3:00 PM CST
0.75% (1Y)
| Market Cap | 19.87B +14.1% |
| Revenue (ttm) | 26.83B +1.1% |
| Net Income | 1.14B +33.8% |
| EPS | 1.01 +35.1% |
| Shares Out | 1.14B |
| PE Ratio | 17.25 |
| Forward PE | 13.94 |
| Dividend | 0.68 (3.99%) |
| Ex-Dividend Date | Nov 6, 2025 |
| Volume | 6,309,869 |
| Average Volume | 4,534,533 |
| Open | 17.18 |
| Previous Close | 17.06 |
| Day's Range | 17.12 - 17.53 |
| 52-Week Range | 15.50 - 21.78 |
| Beta | 0.64 |
| RSI | 42.15 |
| Earnings Date | Apr 24, 2026 |